Descovy Tablet
Product Images NDC 61958-2002

Descovy tablets are a medication used to treat HIV. Each tablet contains 200 mg of emtricitabine and 25 mg of tenofovir lafenamide (equivalent to 28 mg of tenofovir alafenamide fumarate). They should be stored at 25°C (77°F) and dispensed only in the original container. Dosage and administration guidelines can be found in the package insert. This medication is manufactured by Gilead Sciences, Inc. in Canada and should be kept out of reach of children. The package includes an ALERT box advising against taking certain other medications with Descovy. The product code is NDC 61958-2002-1 for a package of 30 tablets, and the copyright is held by Gilead Sciences, Inc. as of 2019.*

NDC 61956-2002:2 is a pack of 30 tablets containing Descovy, a medicine used to treat HIV infection. Each tablet has a composition of 200 mg of emtricitabine and 25 mg of tenofovir alafenamide (equivalent to 28 mg of tenofovir alafenamide fumarate). The tablets are manufactured by Gilead Sciences, Inc and should be stored at a temperature of 2 to 25 °C. Dispensing should be done only in the original container and pharmacists should not cover the ALERT box with their label. Further information on dosage and administration can be found in the package insert.*

Descovy is a medication available in tablet form that consists of 120mg of emtricitabine and 15mg of tenofovir alafenamide or equivalent to 168mg of tenofovir alafenamide fumarate. It should be stored at 25°C and kept out of reach of children, with the container closed tightly. The medication is manufactured by Gilead Sciences in Foster City, CA and distributed in Canada. The recommended dosage and administration instructions can be found in the package insert. The medication may interact with other drugs, and patients should consult a healthcare provider before consuming it.*